300633 开立医疗
已收盘 01-06 15:00:00
资讯
新帖
简况
每周股票复盘：开立医疗（300633）取消监事会并修订章程
证券之星 · 01-03
每周股票复盘：开立医疗（300633）取消监事会并修订章程
股市必读：开立医疗（300633）12月24日董秘有最新回复
证券之星 · 2025-12-25
股市必读：开立医疗（300633）12月24日董秘有最新回复
开立医疗：公司部分董事和高管已实施增持
证券日报 · 2025-12-24
开立医疗：公司部分董事和高管已实施增持
开立医疗：实控人质押资金用于个人消费支出
证券之星 · 2025-12-24
开立医疗：实控人质押资金用于个人消费支出
开立医疗：业绩随行业招标恢复呈逐季好转趋势
证券之星 · 2025-11-26
开立医疗：业绩随行业招标恢复呈逐季好转趋势
开立医疗最新公告：董事、高级管理人员增持公司股份
证券之星 · 2025-11-05
开立医疗最新公告：董事、高级管理人员增持公司股份
开立医疗：单三季度营收增长28.42%
证券之星 · 2025-10-31
开立医疗：单三季度营收增长28.42%
【机构调研记录】益民基金调研瑞尔特、开立医疗
证券之星 · 2025-10-30
【机构调研记录】益民基金调研瑞尔特、开立医疗
开立医疗(300633)9月30日股东户数1.61万户，较上期增加12.75%
证券之星 · 2025-10-28
开立医疗(300633)9月30日股东户数1.61万户，较上期增加12.75%
开立医疗(300633.SZ)发布前三季度业绩，归母净利润3351.11万元，下降69.25%
智通财经 · 2025-10-28
开立医疗(300633.SZ)发布前三季度业绩，归母净利润3351.11万元，下降69.25%
开立医疗（300633）披露2025年限制性股票与股票期权激励计划授予公告，10月17日股价下跌2.59%
证券之星 · 2025-10-17
开立医疗（300633）披露2025年限制性股票与股票期权激励计划授予公告，10月17日股价下跌2.59%
股市必读：开立医疗（300633）9月25日董秘有最新回复
证券之星 · 2025-09-26
股市必读：开立医疗（300633）9月25日董秘有最新回复
开立医疗：三胎政策利好妇产专科超声设备需求
证券之星 · 2025-09-25
开立医疗：三胎政策利好妇产专科超声设备需求
中邮证券：首次覆盖开立医疗给予增持评级
证券之星 · 2025-09-23
中邮证券：首次覆盖开立医疗给予增持评级
股市必读：开立医疗（300633）9月19日披露最新机构调研信息
证券之星 · 2025-09-22
股市必读：开立医疗（300633）9月19日披露最新机构调研信息
开立医疗：9月8日接受机构调研，东吴医药、华源医药等多家机构参与
证券之星 · 2025-09-19
开立医疗：9月8日接受机构调研，东吴医药、华源医药等多家机构参与
9月8日开立医疗涨13.24%，广发医疗保健股票A基金重仓该股
证券之星 · 2025-09-08
9月8日开立医疗涨13.24%，广发医疗保健股票A基金重仓该股
开立医疗(300633.SZ)拟授出191.4万股限制性股票、396.78万份股票期权
智通财经 · 2025-09-05
开立医疗(300633.SZ)拟授出191.4万股限制性股票、396.78万份股票期权
股市必读：开立医疗（300633）9月4日董秘有最新回复
证券之星 · 2025-09-05
股市必读：开立医疗（300633）9月4日董秘有最新回复
开立医疗：公司在超声领域专门推出了适用于动物医疗的产品型号
证券之星 · 2025-09-04
开立医疗：公司在超声领域专门推出了适用于动物医疗的产品型号
加载更多
公司概况
公司名称：
深圳开立生物医疗科技股份有限公司
所属行业：
专用设备制造业
上市日期：
2017-04-06
主营业务：
深圳开立生物医疗科技股份有限公司的主营业务是医疗诊断及治疗设备的自主研发、生产与销售。公司的主要产品是医用超声诊断设备、消化与呼吸内镜、微创外科产品和心血管介入产品。
发行价格：
5.23
{"stockData":{"symbol":"300633","market":"SZ","secType":"STK","nameCN":"开立医疗","latestPrice":27.6,"timestamp":1767683013000,"preClose":27.6,"halted":0,"volume":5314494,"delay":0,"changeRate":0,"floatShares":433000000,"shares":433000000,"eps":0.1547,"marketStatus":"已收盘","change":0,"latestTime":"01-06 15:00:00","open":27.76,"high":27.89,"low":27.31,"amount":146000000,"amplitude":0.021,"askPrice":27.61,"askSize":167,"bidPrice":27.6,"bidSize":172,"shortable":0,"etf":0,"ttmEps":0.1547,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1767749400000},"marketStatusCode":5,"adr":0,"adjPreClose":27.6,"symbolType":"stock","openAndCloseTimeList":[[1767663000000,1767670200000],[1767675600000,1767682800000]],"highLimit":30.36,"lowLimit":24.84,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":432712405,"isCdr":false,"pbRate":3.83,"roa":"--","peRate":178.409825,"roe":"1.07%","epsLYR":0.33,"committee":0.104796,"marketValue":11943000000,"turnoverRate":0.0123,"status":2,"floatMarketCap":11943000000},"requestUrl":"/m/hq/s/300633","defaultTab":"news","newsList":[{"id":"2600067802","title":"每周股票复盘：开立医疗（300633）取消监事会并修订章程","url":"https://stock-news.laohu8.com/highlight/detail?id=2600067802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2600067802?lang=zh_cn&edition=full","pubTime":"2026-01-03 02:31","pubTimestamp":1767378669,"startTime":"0","endTime":"0","summary":"截至2025年12月31日收盘，开立医疗报收于26.42元，较上周的26.55元下跌0.49%。本周关注点公司公告汇总：开立医疗股东大会通过取消监事会及修订公司章程的议案。深圳开立生物医疗科技股份有限公司于2025年12月30日召开职工代表大会，选举冯乃章先生为公司第四届董事会职工代表董事，任期至第四届董事会任期届满。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010300000553.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","300633","SG9999001069.SGD","SG9999006597.SGD","BK0251"],"gpt_icon":0},{"id":"2594409149","title":"股市必读：开立医疗（300633）12月24日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2594409149","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594409149?lang=zh_cn&edition=full","pubTime":"2025-12-25 02:45","pubTimestamp":1766601912,"startTime":"0","endTime":"0","summary":"截至2025年12月24日收盘，开立医疗报收于26.66元，上涨1.41%，换手率0.55%，成交量2.37万手，成交额6315.8万元。董秘最新回复投资者： 董秘你好，请问贵司新业务IVUS 导管耗材和硬镜设备是否导入顺利董秘： 您好，公司微创外科、心血管介入业务发展顺利，近两年均取得较高增速，谢谢。当日关注点来自交易信息汇总：12月24日主力资金净流出606.3万元，散户资金净流入1181.73万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122500001335.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","300633","SG9999001051.SGD","SG9999006597.SGD","SG9999001069.SGD"],"gpt_icon":0},{"id":"2593947014","title":"开立医疗：公司部分董事和高管已实施增持","url":"https://stock-news.laohu8.com/highlight/detail?id=2593947014","media":"证券日报 ","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593947014?lang=zh_cn&edition=full","pubTime":"2025-12-24 22:08","pubTimestamp":1766585280,"startTime":"0","endTime":"0","summary":"证券日报网讯 12月24日，开立医疗在互动平台回答投资者提问时表示，公司部分董事和高管已实施增持。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-24/doc-inhcxizc9660654.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-24/doc-inhcxizc9660654.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["SG9999001069.SGD","SG9999006597.SGD","300633","BK0251","SG9999001051.SGD"],"gpt_icon":0},{"id":"2593244781","title":"开立医疗：实控人质押资金用于个人消费支出","url":"https://stock-news.laohu8.com/highlight/detail?id=2593244781","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593244781?lang=zh_cn&edition=full","pubTime":"2025-12-24 09:24","pubTimestamp":1766539452,"startTime":"0","endTime":"0","summary":"证券之星消息，开立医疗(300633)12月24日在投资者关系平台上答复投资者关心的问题。投资者提问：请问公司实控二人质押股票后的资金去向，投入领域是否与公司有关联关系以及竞争关系？开立医疗回复：您好，公司实控人所持股份质押比例极低，所得资金主要用于个人消费支出，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122400007066.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","SG9999001069.SGD","SG9999006597.SGD","SG9999001051.SGD","300633"],"gpt_icon":0},{"id":"2586236799","title":"开立医疗：业绩随行业招标恢复呈逐季好转趋势","url":"https://stock-news.laohu8.com/highlight/detail?id=2586236799","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2586236799?lang=zh_cn&edition=full","pubTime":"2025-11-26 15:21","pubTimestamp":1764141683,"startTime":"0","endTime":"0","summary":"证券之星消息，开立医疗(300633)11月26日在投资者关系平台上答复投资者关心的问题。投资者提问：你好，据第三方数据统计今年1-10月份，公司中标金额超过10个亿，有多少中标额确认成了今年前三季度收入？开立医疗回复：您好，各个中标项目的收入确认周期不等，从前三季度的数据看，公司业绩随行业招标的恢复呈逐季好转趋势，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025112600017366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","SG9999006597.SGD","BK0251","SG9999001069.SGD","300633"],"gpt_icon":0},{"id":"2581742497","title":"开立医疗最新公告：董事、高级管理人员增持公司股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2581742497","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581742497?lang=zh_cn&edition=full","pubTime":"2025-11-05 17:28","pubTimestamp":1762334903,"startTime":"0","endTime":"0","summary":"开立医疗(300633.SZ)公告称，公司董事兼副总经理黄奕波于11月4日以自有资金增持16万股，增持金额约459万元；董事会秘书兼副总经理李浩于11月5日增持30万股，增持金额约856万元。增持后，黄奕波持股比例升至4.65%，李浩持股比例升至1.84%。此次增持基于对公司未来发展的信心和长期投资价值的认同。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025110500029849.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","300633","SG9999001051.SGD","BK0251","SG9999001069.SGD"],"gpt_icon":0},{"id":"2579746473","title":"开立医疗：单三季度营收增长28.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2579746473","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579746473?lang=zh_cn&edition=full","pubTime":"2025-10-31 20:51","pubTimestamp":1761915106,"startTime":"0","endTime":"0","summary":"证券之星消息，开立医疗10月30日在投资者关系平台上答复投资者关心的问题。开立医疗回复：您好，公司2025年1-9月营业收入同比增长4.37%，与公司2025年一季度收入同比下滑10.29%、2025年半年度收入同比下滑4.78%对比，公司收入逐季改善趋势明显。尤其是公司2025年单三季度营业收入取得28.42%的增长，单三季度净利润相比上年同期大幅减亏，符合公司预期，公司将尽力完成2025年股权激励业绩目标。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103100047192.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633"],"gpt_icon":0},{"id":"2579561011","title":"【机构调研记录】益民基金调研瑞尔特、开立医疗","url":"https://stock-news.laohu8.com/highlight/detail?id=2579561011","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579561011?lang=zh_cn&edition=full","pubTime":"2025-10-30 08:07","pubTimestamp":1761782836,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及10月29日披露的机构调研信息，益民基金近期对2家上市公司进行了调研，相关名单如下：1）瑞尔特 调研纪要：2025前三季度，公司实现营业收入13.63亿元，同比下滑20.26%，归母净利润6157.37万元，同比下降51.26%。毛利率为26.07%，同比下滑1.36个百分点，期间费用率上升2.28个百分点。毛利率下降主要因超声集采及新产品结构影响。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025103000008579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","300633","SG9999006597.SGD","BK0251","BK0220","SG9999001051.SGD","002790"],"gpt_icon":0},{"id":"2578939790","title":"开立医疗(300633)9月30日股东户数1.61万户，较上期增加12.75%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578939790","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578939790?lang=zh_cn&edition=full","pubTime":"2025-10-28 17:41","pubTimestamp":1761644503,"startTime":"0","endTime":"0","summary":"户均持股数量由上期的3.02万股减少至2.68万股，户均持股市值为92.22万元。在医疗器械行业个股中，开立医疗股东户数低于行业平均水平，截至9月30日，医疗器械行业平均股东户数为2.15万户。从股价来看，2025年6月30日至2025年9月30日，开立医疗区间涨幅为15.68%，在此期间股东户数增加1824.0户，增幅为12.75%。根据统计，开立医疗2025年6月30日至2025年9月30日，主力资金净流出4.74亿元，游资资金净流出1.5亿元，散户资金净流入6.24亿元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025102800032326.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001069.SGD","SG9999006597.SGD","300633","BK0251","SG9999001051.SGD"],"gpt_icon":0},{"id":"2578938094","title":"开立医疗(300633.SZ)发布前三季度业绩，归母净利润3351.11万元，下降69.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2578938094","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2578938094?lang=zh_cn&edition=full","pubTime":"2025-10-28 16:39","pubTimestamp":1761640764,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开立医疗(300633.SZ)发布2025年三季度报告，该公司前三季度营业收入为14.59亿元，同比增长4.37%。归属于上市公司股东的净利润为3351.11万元，同比减少69.25%。归属于上市公司股东的扣除非经常性损益的净利润为2399.1万元，同比减少72.15%。基本每股收益为0.0774元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1361233.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"开立医疗(300633.SZ)发布前三季度业绩，归母净利润3351.11万元，下降69.25%","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300633"],"gpt_icon":0},{"id":"2576051692","title":"开立医疗（300633）披露2025年限制性股票与股票期权激励计划授予公告，10月17日股价下跌2.59%","url":"https://stock-news.laohu8.com/highlight/detail?id=2576051692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576051692?lang=zh_cn&edition=full","pubTime":"2025-10-17 22:43","pubTimestamp":1760712188,"startTime":"0","endTime":"0","summary":"截至2025年10月17日收盘，开立医疗报收于33.05元，较前一交易日下跌2.59%，最新总市值为143.01亿元。该股当日开盘34.0元，最高34.15元，最低32.98元，成交额达1.24亿元，换手率为0.86%。本次激励计划的授予日为2025年10月16日，有效期最长不超过60个月，权益归属和行权安排分为四期，每期各占25%。此次激励计划已履行相关决策程序，不包括独立董事、监事、外籍员工及持股5%以上股东及其关联人。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025101700038700.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999001051.SGD","SG9999001069.SGD","300633","SG9999006597.SGD","BK0251"],"gpt_icon":0},{"id":"2570010570","title":"股市必读：开立医疗（300633）9月25日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2570010570","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570010570?lang=zh_cn&edition=full","pubTime":"2025-09-26 01:00","pubTimestamp":1758819646,"startTime":"0","endTime":"0","summary":"截至2025年9月25日收盘，开立医疗报收于35.07元，上涨0.46%，换手率0.8%，成交量3.45万手，成交额1.2亿元。董秘最新回复投资者： 全面三胎政策实施后，对公司布局妇产科方向有利好吗？当日关注点来自交易信息汇总：9月25日主力资金净流出489.11万元，显示主力小幅离场。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092600000464.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300633","SG9999001051.SGD","BK0251","SG9999006597.SGD","SG9999001069.SGD"],"gpt_icon":0},{"id":"2570051656","title":"开立医疗：三胎政策利好妇产专科超声设备需求","url":"https://stock-news.laohu8.com/highlight/detail?id=2570051656","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2570051656?lang=zh_cn&edition=full","pubTime":"2025-09-25 11:36","pubTimestamp":1758771375,"startTime":"0","endTime":"0","summary":"证券之星消息，开立医疗(300633)09月25日在投资者关系平台上答复投资者关心的问题。投资者提问：全面三胎政策实施后，对公司布局妇产科方向有利好吗？开立医疗回复：您好，该政策对妇产专科超声等医疗设备的需求有所利好，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092500012822.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","300633","SG9999001051.SGD","BK0251","SG9999001069.SGD"],"gpt_icon":0},{"id":"2569926752","title":"中邮证券：首次覆盖开立医疗给予增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2569926752","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569926752?lang=zh_cn&edition=full","pubTime":"2025-09-23 09:24","pubTimestamp":1758590640,"startTime":"0","endTime":"0","summary":"中邮证券有限责任公司盛丽华,陈峻近期对开立医疗进行研究并发布了研究报告《业绩短期承压，期待下半年新品放量》，首次覆盖开立医疗给予增持评级。开立医疗(300633) l业绩简评公司发布2025 ...","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://stock.10jqka.com.cn/hks/20250923/c671341902.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tonghuashun","symbols":["300633","161027"],"gpt_icon":0},{"id":"2569220139","title":"股市必读：开立医疗（300633）9月19日披露最新机构调研信息","url":"https://stock-news.laohu8.com/highlight/detail?id=2569220139","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2569220139?lang=zh_cn&edition=full","pubTime":"2025-09-22 03:16","pubTimestamp":1758482175,"startTime":"0","endTime":"0","summary":"截至2025年9月19日收盘，开立医疗报收于34.45元，下跌0.66%，换手率0.75%，成交量3.25万手，成交额1.12亿元。当日关注点来自交易信息汇总：9月19日主力资金净流出519.3万元，散户资金净流入342.84万元。来自机构调研要点：内镜HD-650上半年实现小批量销售，预计全年将放量，三甲医院多镜体配置订单占比提升。目前三甲医院对 HD-650的采购订单中多镜体配置订单占比提升，标准配置已由以往两镜体增至四条镜体，反映公司产品的临床接受度和产品竞争力持续增强。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025092200001074.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","SG9999001051.SGD","SG9999006597.SGD","300633","SG9999001069.SGD"],"gpt_icon":0},{"id":"2568254660","title":"开立医疗：9月8日接受机构调研，东吴医药、华源医药等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2568254660","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2568254660?lang=zh_cn&edition=full","pubTime":"2025-09-19 18:03","pubTimestamp":1758276211,"startTime":"0","endTime":"0","summary":"证券之星消息，2025年9月19日开立医疗发布公告称公司于2025年9月8日接受机构调研，东吴医药、华源医药、甬兴医药、瑞银证券、信达证券、鹏华基金、国泰基金、大成基金、银河证券、山西证券、中信证券参与。目前三甲医院对 HD-650的采购订单中多镜体配置订单占比提升，标准配置已由以往两镜体增至四条镜体，反映公司产品的临床接受度和产品竞争力持续增强。开立医疗主营业务：医疗诊断及治疗设备的自主研发、生产与销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025091900027626.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1574","BK0251","SG9999006597.SGD","BK1515","300633","SG9999001069.SGD","159938","SG9999001051.SGD","09939","BK1161"],"gpt_icon":0},{"id":"2565501100","title":"9月8日开立医疗涨13.24%，广发医疗保健股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2565501100","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565501100?lang=zh_cn&edition=full","pubTime":"2025-09-08 16:32","pubTimestamp":1757320342,"startTime":"0","endTime":"0","summary":"证券之星消息，9月8日开立医疗涨13.24%创60日新高，收盘报36.61元，换手率5.8%，成交量25.09万手，成交额9.0亿元。该股为医疗器械、体外诊断概念热股。根据2025基金半年报公募基金重仓股数据，重仓该股的公募基金共30家，其中持有数量最多的公募基金为广发基金的广发医疗保健股票A。广发医疗保健股票A目前规模为52.47亿元，最新净值2.1796，较上一交易日上涨2.75%，近一年上涨42.54%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090800020820.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["SG9999006597.SGD","SG9999001051.SGD","300633","SG9999001069.SGD","BK0251"],"gpt_icon":0},{"id":"2565550446","title":"开立医疗(300633.SZ)拟授出191.4万股限制性股票、396.78万份股票期权","url":"https://stock-news.laohu8.com/highlight/detail?id=2565550446","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565550446?lang=zh_cn&edition=full","pubTime":"2025-09-05 20:05","pubTimestamp":1757073940,"startTime":"0","endTime":"0","summary":"智通财经APP讯，开立医疗(300633.SZ)披露2025年限制性股票与股票期权激励计划(草案)，公司拟向激励对象授予第二类限制性股票数量为191.4万股，授予396.78万份股票期权。本激励计划第二类限制性股票的授予价格为不低于15.93元/股，股票期权的行权价格为不低于31.86元/份。本激励计划授予的激励对象总人数共计406人，包括公司部分董事及高级管理人员、公司(含分公司及控股子公司)中层管理人员和技术业务骨干。本激励计划有效期自第二类限制性股票/股票期权授予/授权之日起至激励对象获授的第二类限制性股票/股票期权全部归属/行权或作废失效/注销之日止，最长不超过60个月。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1342171.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["SG9999006597.SGD","SG9999001051.SGD","SG9999001069.SGD","BK0251","300633"],"gpt_icon":0},{"id":"2565024593","title":"股市必读：开立医疗（300633）9月4日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2565024593","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2565024593?lang=zh_cn&edition=full","pubTime":"2025-09-05 03:03","pubTimestamp":1757012594,"startTime":"0","endTime":"0","summary":"截至2025年9月4日收盘，开立医疗报收于31.6元，下跌1.31%，换手率0.94%，成交量4.05万手，成交额1.29亿元。董秘最新回复投资者： 为何公司经常有投资者去公司调研交流，公司不及时发布交流内容？","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090500002579.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","SG9999001051.SGD","SG9999006597.SGD","300633","SG9999001069.SGD"],"gpt_icon":0},{"id":"2564234503","title":"开立医疗：公司在超声领域专门推出了适用于动物医疗的产品型号","url":"https://stock-news.laohu8.com/highlight/detail?id=2564234503","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2564234503?lang=zh_cn&edition=full","pubTime":"2025-09-04 09:06","pubTimestamp":1756947969,"startTime":"0","endTime":"0","summary":"证券之星消息，开立医疗(300633)09月04日在投资者关系平台上答复投资者关心的问题。投资者提问：公司产品可以用于宠物领域吗？开立医疗回复：您好，公司在超声领域专门推出了适用于动物医疗的产品型号，并在国内外均有销售，谢谢。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025090400006596.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159891","SG9999001069.SGD","BK0251","SG9999006597.SGD","SG9999001051.SGD","300633"],"gpt_icon":0}],"profile":{"ret":0,"serverTime":1767735224941,"stockEarnings":[{"period":"1week","weight":0.0534},{"period":"1month","weight":0.0245},{"period":"3month","weight":-0.1972},{"period":"6month","weight":-0.0336},{"period":"1year","weight":-0.0583},{"period":"ytd","weight":0.0447}],"compareEarnings":[{"period":"1week","weight":0.0299},{"period":"1month","weight":0.0463},{"period":"3month","weight":0.0517},{"period":"6month","weight":0.1635},{"period":"1year","weight":0.2734},{"period":"ytd","weight":0.0289}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"深圳开立生物医疗科技股份有限公司","boardCode":"AI0035","boardName":"专用设备制造业","stockholders":"16131人(较上一季度增加12.75%)","perCapita":"26824股","listingDate":"2017-04-06","address":"广东省深圳市南山区粤海街道麻岭社区高新中区科技中2路1号深圳软件园(2期)12栋201、202","registeredCapital":"43271万元","survey":" 深圳开立生物医疗科技股份有限公司的主营业务是医疗诊断及治疗设备的自主研发、生产与销售。公司的主要产品是医用超声诊断设备、消化与呼吸内镜、微创外科产品和心血管介入产品。","listedPrice":5.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"开立医疗(300633)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供开立医疗(300633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"开立医疗,300633,开立医疗股票,开立医疗股票老虎,开立医疗股票老虎国际,开立医疗行情,开立医疗股票行情,开立医疗股价,开立医疗股市,开立医疗股票价格,开立医疗股票交易,开立医疗股票购买,开立医疗股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"开立医疗(300633)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供开立医疗(300633)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}